Paula Ragan, President and CEO at X4 Pharmaceuticals, Inc (XFOR), sold 1,797 shares at $7.00 ($13K) on 2020-10-05, disclosed to the SEC on 2020-10-06.
Scheduled sale ($13k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| XFOR | SELL | 2024-10-16 | $18K | — | Filing → |
| XFOR | SELL | 2024-10-08 | $263K | — | Filing → |
| XFOR | SELL | 2024-03-11 | $44K | — | Filing → |